Drawing for TULA

USPTO serial 88591646

TULA

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CHADAB, SETH WILLIG
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with TULA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,294*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul N. Taylor

Paul N. Taylor Ray Quinney & Nebeker36 South State StreetSuite 1400Salt Lake City, UT 84111

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer software and hardware for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data sold as a unit; Wearable non-invasive medical monitoring device in the nature of computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting, and displaying data; Wearable activity trackersACTIVE—
010Medical device, namely, a device for measuring and monitoring glucose levels; Medical device, namely, a device for measuring and monitoring diabetes; Medical device, namely, a device for measuring and monitoring a metabolic syndrome; Medical devices, namely, medical sensors used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers and sensor housings; Medical device, namely, a device for measuring and monitoring congestive heart failure; Medical device, namely, a device for measuring and monitoring hydration levels; Medical device, namely, a device for monitoring and monitoring hydration levels; Medical device, namely, a device for monitoring and monitoring chronic obstructive pulmonary disease; Medical device, namely, a device for monitoring and monitoring asthma; Wearable non-invasive medical monitoring device in the nature of wearable monitors used to measure biometric data for medical useACTIVE—
035Data compiling, analyzing and processing services in the field of healthcare, and medical insurance; Database management, namely, business data compiling and analyzing in the field of healthcareACTIVE—
041Educational services, namely, providing coaching programs and training in the field of management and measurement of glucose levels, and the diagnosis, management and treatment of diabetes; Educational services, namely, providing coaching programs and training in connection with the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data; Developing and distributing educational program course materials in connection with the aforementioned servicesACTIVE—
042Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reportsACTIVE—
044Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical conditions and treatment purposes; Medical assistance services provided via telecommunication and global computer networks for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; Medical services, namely, providing medical information, medical data, medical counseling, medical patient and physician support, and medical consulting services in the field of blood glucose level and diabetes monitoring and treatment systems; Medical data services in the nature of maintaining files and records concerning the medical condition of individuals in connection with the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2026EX5GSOU EXTENSION 5 GRANTED—
Jun 22, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 10, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2026EXT5SOU EXTENSION 5 FILED—
Oct 10, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 10, 2025EXT4SOU EXTENSION 4 FILED—
Oct 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2025EX3GSOU EXTENSION 3 GRANTED—
Apr 11, 2025EXT3SOU EXTENSION 3 FILED—
Apr 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 10, 2024EXT2SOU EXTENSION 2 FILED—
Oct 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 17, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2024EX1GSOU EXTENSION 1 GRANTED—
Apr 16, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 10, 2024EXT1SOU EXTENSION 1 FILED—
Apr 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 5, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 2, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 3, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 19, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 2, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 2, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Jun 2, 2020CNSLSUSPENSION LETTER WRITTEN—
May 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2020ALIEASSIGNED TO LIE—
Apr 30, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 27, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 27, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 27, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2019DOCKASSIGNED TO EXAMINER—
Sep 8, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance